The emerging role of human PYHIN proteins in innate immunity: Implications for health and disease
Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway
Proapoptotic PEDF functional peptides inhibit prostate tumor growth—A mechanistic study
Identification of a novel partial agonist of liver X receptor α (LXRα) via screening
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo
Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), “silent” with mivacurium
Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway
Crystals of Na+/K+-ATPase with bound cisplatin
Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1
In vitro inhibition of lysine decarboxylase activity by organophosphate esters
Corrigendum to “Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: Possible mechanism of cardioprotection” [Biochem. Pharmacol. 86 (2013) 1301–1310],
Corrigendum to “P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway” [Biochem. Pharmacol. 86 (2013) 584–596],